Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Woolworths | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$36.50B | 335.2x | -3.69 | A$29.92 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.1% Upside | Upgrade to Pro+ | |
Coles Group | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$25.74B | 23x | 12.92 | A$19.27 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.2% Upside | Upgrade to Pro+ | |
Endeavour Group | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$7.52B | 18.6x | -4.6 | A$4.20 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.7% Upside | Upgrade to Pro+ | |
Metcash | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$3.40B | 12.8x | -0.96 | A$3.10 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.4% Upside | Upgrade to Pro+ | |
Jatcorp | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$34.97M | 15.6x | 0.1 | A$0.42 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Aumake | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$15.04M | -1.3x | 0.26 | A$0.005 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |